WAM
TEVA icon

Wallington Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Wallington Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,150
Closed -$355K – 62
2017
Q3 		$355K Sell
20,150
-1,455
-7% -$32.7K 0.09% 53
2017
Q2 		$718K Sell
21,605
-1,140
-5% -$35.3K 0.2% 48
2017
Q1 		$730K Sell
22,745
-895
-4% -$30.5K 0.21% 50
2016
Q4 		$857K Sell
23,640
-23,755
-50% -$948K 0.27% 48
2016
Q3 		$2.18M Sell
47,395
-2,510
-5% -$131K 0.72% 42
2016
Q2 		$2.51M Sell
49,905
-190
-0.4% -$10.1K 0.78% 41
2016
Q1 		$2.68M Sell
50,095
-870
-2% -$51K 0.88% 38
2015
Q4 		$3.35M Sell
50,965
-120
-0.2% -$7.42K 1.15% 33
2015
Q3 		$2.88M Sell
51,085
-680
-1% -$44.1K 1.04% 38
2015
Q2 		$3.06M Sell
51,765
-1,590
-3% -$98.1K 0.98% 41
2015
Q1 		$3.32M Sell
53,355
-1,040
-2% -$60.5K 1.04% 41
2014
Q4 		$3.13M Sell
54,395
-730
-1% -$40.7K 1% 42
2014
Q3 		$2.96M Sell
55,125
-710
-1% -$37.6K 1% 40
2014
Q2 		$2.93M Sell
55,835
-5,265
-9% -$269K 1% 40
2014
Q1 		$3.23M Sell
61,100
-1,800
-3% -$83.2K 1.14% 40
2013
Q4 		$2.52M Sell
62,900
-730
-1% -$28.7K 0.92% 41
2013
Q3 		$2.4M Buy
63,630
+1,630
+3% +$63.6K 0.99% 39
2013
Q2 		$2.43M Buy
+62,000
New +$2.41M 1.03% 38

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Wallington Asset Management's TEVA Position: Q4 2017 in Review

Wallington Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 20,150 shares — an estimated $355K sold.

Wallington Asset Management first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $3.35M in Q4 2015. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Wallington Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Wallington Asset Management sold 20,150 Teva Pharmaceuticals shares in Q4 2017, an estimated $355K.
  • Wallington Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Wallington Asset Management's Teva Pharmaceuticals position peaked at $3.35M in Q4 2015.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Wallington Asset Management's 13F filing for Q4 2017, filed 6 Feb 2018.